Trimosulfa
Trimosulfa, a combination of trimethoprim and sulfamethoxazole, is a sequential dual folate synthesis inhibitor effective against a broad spectrum of bacteria. It is widely used in research for studying antimicrobial mechanisms and efficacy in both in vitro susceptibility assays and in vivo infection models.
Product Specifications
CAS Number
8064-90-2
Product Name Alternative
Cotrimoxazole, TMP-SMX, Sulfamethoxazole-trimethoprim, Trimosulfa, Trimforte, Trimethoprim/sulfamethoxazole 1:5, Trimethoprimsulfa, Trimethoprim-sulfamethoxazole
Field of Research
Infectious Disease & Virology, Metabolism Research
Purity
99.93% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.2 mM) ; DMSO:80 mg/mL (147.17 mM)
Smiles
O=S (=O) (NC1=NOC (=C1) C) C2=CC=C (N) C=C2.N=1C=C (C (=NC1N) N) CC2=CC (OC) =C (OC) C (OC) =C2
Molecular Formula
C24H29N7O6S
Molecular Weight
543.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040608-ML650 100 µL
PTEN, phosphorylated (S362) (PTEN, MMAC1, TEP1, Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, Mutated in multiple advanced cancers 1, Phosphatase and tensin homolog) (MaxLight 650) discontinued
Sign In for Pricing
View Details 
IBCTLXNRNHISLY10UG 1 Each
Bacteria-Derived Latexin Recombinant Protein N-His Tag Lyophilized
Sign In for Pricing
View Details 